title: Synchronous primary carcinoma of breast and ovary versus ovarian metastases.
authors.forename: Budhi S
authors.initials: BS
authors.lastname: Yadav
authors.forename: S C
authors.initials: SC
authors.lastname: Sharma
authors.forename: Tyler P
authors.initials: TP
authors.lastname: Robin
authors.forename: Sharon
authors.initials: S
authors.lastname: Sams
authors.forename: Anothony D
authors.initials: AD
authors.lastname: Elias
authors.forename: Virginia
authors.initials: V
authors.lastname: Kaklamani
authors.forename: P
authors.initials: P
authors.lastname: Kelly Marcom
authors.forename: Sara
authors.initials: S
authors.lastname: Schaefer
authors.forename: Gloria J
authors.initials: GJ
authors.lastname: Morris
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000175:diagnosis* / Q000628:therapy; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents